References
- Meissner Y, Lamprecht A. (2008). Alternative drug delivery approaches for the therapy of inflammatory bowel disease. J Pharm Sci, 97:2878–91.
- Bondesen S. (1997). Intestinal fate of 5-aminosalicylic acid: Regional and systemic kinetic studies in relation to inflammatory bowel disease. Pharmacol Toxicol, 81(Suppl 2):1–28.
- Haupt S, Rubinstein A. (2002). The colon as a possible target for orally administered peptides and proteins. Crit Rev Ther Drug Carrier Syst, 19:499–545.
- Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: New approaches and in vitro/in vivo evaluation. Int J Pharm, 235:1–15.
- Semde R, Moës AJ, Devleeschouwer MJ, Amighi K. (2003). Synthesis and enzymatic degradation of epichlorohydrin cross-linked pectins. Drug Dev Ind Pharm, 29:203–13.
- Onishi H, Oosegi T, Machida Y, McGinity JW. (2005). Preparation and in vitro evaluation of chitosan microspheres containing prednisolone: Comparison of simple and conjugate microspheres. Drug Dev Ind Pharm, 31:597–605.
- Cummings JH, Milojevic S, Harding M, Coward WA, Gibson GR, Botham RL, (1996). In vivo studies of amylose- and ethylcellulose-coated [13C] glucose microspheres as a model for drug delivery to the colon. J Control Release, 40:123–31.
- Milojevic S, Newton JM, Cummings JH, Gibson GR, Botham RL, Ring SG, (1996). Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J Control Release, 38:75–84.
- Milojevic S, Newton JM, Cummings JH, Gibson GR, Botham RL, Ring SG, (1996). Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets. J Control Release, 38:85–94.
- Gazzaniga A, Iamartino P, Maffione G, Sangalli ME. (1994). Oral delayed-release system for colonic specific delivery. Int J Pharm, 108:77–83.
- Gazzaniga A, Sangalli ME, Giordano F. (1994). Oral Chronotropic drug delivery systems: Achievement of time and/or site specificity. Eur J Pharm Biopharm, 40:246–50.
- Gazzaniga A, Maroni A, Sangalli ME, Zema L. (2006). Time-controlled oral delivery systems for colon targeting. Expert Opin Drug Deliv, 3:583–97.
- Sangalli ME, Maroni A, Zema L, Busetti C, Giordano F, Gazzaniga A. (2001). In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J Control Release, 73:103–10.
- Siccardi D, Turner JR, Mrsny J. (2005). Regulation of intestinal epithelial function: A link between opportunities for macromolecular drug delivery and inflammatory bowel disease. Adv Drug Deliv Rev, 57:219–35.
- El Yamani J, Mizon C, Capon C, Colombel JF, Fournet B, Cortot A, (1992). Decreased fecal exoglycosidase activities identify a subset of patients with active Crohn's Disease. Clin Sci, 83:409–15.
- Carrette O, Favier C, Mizon C, Neut C, Cortot A, Colombel JF, (1995). Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's Diseases. Dig Dis Sci, 40:2641–6.
- Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. (1997). Fecal β-d-galactosidase production and bifidobacteria are decreased in Crohn's disease. Dig Dis Sci, 42:817–22.
- Friend DR. (2005). New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev, 57:247–65.
- Karrout Y, Neut C, Wils D, Siepmann F, Deremaux L, Dubreuil L, (2009). Colon targeting with bacteria-sensitive films adapted to the disease state, submitted,
- McConnell EL, Tutas J, Mohamed MAM, Banning D, Basit AW. (2007). Colonic drug delivery using amylose films: The role of aqueous ethylcellulose dispersions in controlling drug release. Cellulose, 14:25–34.
- Wesseling M, Bodmeier R. (1999). Drug release from beads coated with an aqueous colloidal ethylcellulose dispersion, Aquacoat®, or an organic ethylcellulose solution. Eur J Pharm Biopharm, 47:33–8.
- Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. (2005). Blends of aqueous polymer dispersions used for pellet coating: Importance of the particle size. J Control Release, 105:226–39.